These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19801041)

  • 41. Letter by ElBardissi regarding article, "Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy".
    Elbardissi AW
    Circulation; 2009 Feb; 119(4):e187; author reply e188. PubMed ID: 19188515
    [No Abstract]   [Full Text] [Related]  

  • 42. New centre to revolutionise cardiac care in Africa.
    Delport R
    Cardiovasc J Afr; 2014; 25(6):303-4. PubMed ID: 25629719
    [No Abstract]   [Full Text] [Related]  

  • 43. Fifty years of hypertrophic cardiomyopathy.
    Roberts WC
    Am J Cardiol; 2009 Feb; 103(3):431-4. PubMed ID: 19166704
    [No Abstract]   [Full Text] [Related]  

  • 44. Extensive myocardial fibrosis in a patient with hypertrophic cardiomyopathy and ventricular tachycardia without traditional high-risk features.
    Bongioanni S; Spirito P; Masi AS; Chiribiri A; Bonamini R; Conte MR
    Circ Cardiovasc Imaging; 2009 Jul; 2(4):349-50. PubMed ID: 19808616
    [No Abstract]   [Full Text] [Related]  

  • 45. Pioneers in cardiology: Vincent Dor, MD. Interview by Mark Nicholls.
    Dor V
    Circulation; 2007 Jun; 115(25):f127-9. PubMed ID: 17592087
    [No Abstract]   [Full Text] [Related]  

  • 46. Hypertrophic cardiomyopathy, fibrosis, and aortic stiffness: an unidentified association unraveled by magnetic resonance imaging.
    Kühl HP
    J Am Coll Cardiol; 2009 Jul; 54(3):263-4. PubMed ID: 19589440
    [No Abstract]   [Full Text] [Related]  

  • 47. [Sudden unexpected death--hypertrophic cardiomyopathy--genetically verified post-mortem].
    Larsen MK; Lundemose JB; Jensen HK; Kristensen IB
    Ugeskr Laeger; 2009 Sep; 171(39):2835-6. PubMed ID: 19811757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The hospitalizations in hypertrophic cardiomyopathy: "The dark side of the moon".
    Monda E; Limongelli G
    Int J Cardiol; 2020 Nov; 318():101-102. PubMed ID: 32810552
    [No Abstract]   [Full Text] [Related]  

  • 49. [Patient information center at the Bad Krozingen Heart Center: structuring patient education].
    Imbery C; Sailer M
    Pflege Z; 2009 Mar; 62(3):150-3. PubMed ID: 19348403
    [No Abstract]   [Full Text] [Related]  

  • 50. A lion never dies: pro memoria of Marc-Vivien Foé.
    Dvorak J
    Br J Sports Med; 2009 Sep; 43(9):628. PubMed ID: 19734494
    [No Abstract]   [Full Text] [Related]  

  • 51. Transcoronary ablation of septal hypertrophy (Tash).
    Sathyamurthy I
    Indian Heart J; 2006; 58(4):371-4. PubMed ID: 19039161
    [No Abstract]   [Full Text] [Related]  

  • 52. [A new type of "tracing" for cardiologists?].
    Baldi M; Girolami F
    G Ital Cardiol (Rome); 2009 Apr; 10(4):266. PubMed ID: 19475884
    [No Abstract]   [Full Text] [Related]  

  • 53. Cardiomyopathy centers in Greece.
    Parcharidis G
    Hellenic J Cardiol; 2011; 52(1):93-4. PubMed ID: 21292615
    [No Abstract]   [Full Text] [Related]  

  • 54. High prevalence of abnormal nocturnal oximetry in patients with hypertrophic cardiomyopathy.
    Eleid MF; Konecny T; Orban M; Sengupta PP; Somers VK; Parish JM; Mookadam F; Brady PA; Sullivan BL; Khandheria BK; Ommen SR; Tajik AJ
    J Am Coll Cardiol; 2009 Nov; 54(19):1805-9. PubMed ID: 19874995
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Impressions of a visit to the Berlin Cardiology Center].
    Trekova NA; Koroteev AV
    Anesteziol Reanimatol; 2006; (5):37-40. PubMed ID: 17184060
    [No Abstract]   [Full Text] [Related]  

  • 56. [The Institut de Cardiologie de Québec].
    Jobin JB
    Laval Med; 1969 Feb; 40(2):225-8. PubMed ID: 5771300
    [No Abstract]   [Full Text] [Related]  

  • 57. Perioperative cardiology: an inspiring arena for the Chameleon doctor.
    Caramelli B
    Heart; 2016 Oct; 102(20):1610-1. PubMed ID: 27406837
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.
    Maron MS; Appelbaum E; Harrigan CJ; Buros J; Gibson CM; Hanna C; Lesser JR; Udelson JE; Manning WJ; Maron BJ
    Circ Heart Fail; 2008 Sep; 1(3):184-91. PubMed ID: 19808288
    [TBL] [Abstract][Full Text] [Related]  

  • 59. What causes outflow tract obstruction in hypertrophic cardiomyopathy?
    Ommen SR; Nishimura RA
    Heart; 2009 Nov; 95(21):1725-6. PubMed ID: 19628468
    [No Abstract]   [Full Text] [Related]  

  • 60. Sonographers' communication: scanning around the world.
    J Am Soc Echocardiogr; 2008 Oct; 21(10):A28. PubMed ID: 18926387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.